Press Releases 2019

Sabinsa Opens Sales Office in Poland to Serve Eastern Europe
September 03, 2019

Sabinsa continues its global expansion with the opening of a warehousing, sales and distribution office in Poland and b…

Sabinsa’s Four Indian Manufacturing Sites Achieve FSSC 22000 Certification
August 19, 2019

Sabinsa’s four Sami Labs manufacturing sites in India were recently audited by the licensed Certification Body, Bureau …

New Research Expands upon Use of Sabinsa’s Curcumin C3 Complex® as an Adjunct to Chemotherapy
June 25, 2019

Sabinsa’s Curcumin C3 Complex® has been studied as an adjuvant therapy with several cancer drugs in the past, and the body of science continues to grow with the recent publication of more positive research.…

Sabinsa’s Curcumin C3 Reduct® Self-Affirmed GRAS
May 29, 2019

After a comprehensive review of safety and toxicology data by an independent panel of scientists of international repute convened by Soni & Associates Inc., Sabinsa’s patented color-free Curcumin C3 Reduct® tetrahydrocurcuminoids…

Sabinsa Achieves USP GMP Audited Status for Three Additional Sites
May 21, 2019

Three additional Sami-Sabinsa Group Manufacturing units have been audited by the United States Pharmacopeia (USP) and received GMP compliance certificates for the Kunigal unit and the Dobaspet unit, both in Bengaluru, India…

Published Analysis of Curcumin Research Provides Comprehensive Overview
May 02, 2019

A retrospective analysis of curcumin research presented a comprehensive look at the vast body of science on the popular extract of turmeric. Curcumin: Total-Scale Analysis of the Scientific Literature by Dr. Atanas G. Atanasov et al.,

Sabinsa to Feature New Patent Protected Products at NYSCC Suppliers’ Day
April 27, 2019

Sabinsa will feature two new patent-protected branded ingredients at New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day tradeshow May 7 – 8, 2019, at the Jacob K. Javits Convention Center in New York City…

Sabinsa’s Manufacturing Arm Receives Research Funding From The Government of India
April 23, 2019

The Department of Scientific and Industrial Research (DSIR), under the Government of India’s Ministry of Science and Technology has sanctioned funding to Sabinsa’s parent company Sami Labs for research on…

Sabinsa’s Biotechnology Site Achieves USP GMP Audited Status
April 08, 2019

The Sami-Sabinsa Group’s Nelamangala biotechnology site in Bengaluru, India has been audited by the United States Pharmacopeia (USP) and received a GMP compliance certificate on February 25, 2019…

Sabinsa Awarded New Patents for ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
April 04, 2019

Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled Process and compositions for achieving mammalian energy balance

Sabinsa Launches LactoSporin®: Novel Probiotic Metabolite For Skin and Hair
March 29, 2019

Sabinsa announces the introduction of LactoSporin® an ingredient for cosmeceutical products that has antimicrobial, antioxidant, anti-inflammatory, and anti-collagenase properties, shows protective efficacy against UV radiation…

Sabinsa Scientist Dr. Natarajan honored by IASTAM for Nutraceutical Product Development
March 21, 2019

The Sami-Sabinsa Group’s Executive Vice President of R&D and Senior Advisor Dr. Sankaran Natarajan was honored by the Indian Association for the Study of Traditional Asian Medicine (IASTAM)…

Sabinsa Appoints Lori Diez Sales Manager - Texas
February 28, 2019

Sabinsa is pleased to announce that Lori Diez has joined the company as Sales Manager - Texas. Lori joins Sabinsa with 12 years of experience as a diabetes care specialist in specialty pharmaceutical sales for a large…

Sabinsa Shagandha Ashwagandha Root Extract 2.5% Designed to Meet USP Monograph, Verified by Prominent Botanical Testing Expert Alkemist Labs
February 11, 2019

Sabinsa has raised the quality bar for the popular adaptogen ashwagandha with Shagandha™ Ashwagandha Root Extract 2.5% USP from Withania somnifera, assured to comply with the U.S. Pharmacopoeia-National Formulary (USP-NF) monograph…

Published Study Reaffirms Function and Survival of Sabinsa’s LactoSpore®
January 07, 2019

A recent peer-reviewed study reported the results of an investigation into the functional aspects of Sabinsa’s shelf stable probiotic Bacillus coagulans MTCC 5856, known worldwide as LactoSpore®